Institute for Wealth Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Institute for Wealth Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.44K	Buy	+141	New	+$1.93K	﹤0.01%	1563

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Westshore Wealth Newport Beach, California $322M AUM 24.46% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Institute for Wealth Management's AMRX Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 141 shares worth $2.44K. The stake represents ﹤0.01% of the portfolio and ranks #1563 among its holdings.

136 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Institute for Wealth Management held 141 shares of Amneal Pharmaceuticals worth $2.44K as of Q2 2026.
Amneal Pharmaceuticals was a new Institute for Wealth Management position in Q2 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1563 holding.
136 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.